ConductScience.org, home

Trial · NCT02478359

Outcomes34

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Deaths Among Participants12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Hospitalizations12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Emergency Department Visits12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Observation Stays12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays12 months following randomizationITT PopulationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With COPD Exacerbation12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCOPD Assessment Test, CAT - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYPhysical Activity12 monthsITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPersonal Health Questionnaire, PHQ8 - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYGeneral Anxiety Disorder, GAD-7 - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYPROMIS-10 HRQL , Physical Health - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYPROMIS-10 HRQL , Mental Health - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYDiastolic Blood Pressure12 months following randomizationITT populationmmHgMEAN
SECONDARYSystolic Blood Pressure12 months following randomizationITT populationmmHgMEAN
SECONDARYHbA1c Levels12 months following randomizationITT populationpercentage of glycosylated hemoglobin,MEAN
SECONDARYLDL Levels12 months following randomizationITT populationmg/dLMEAN
SECONDARYHDL Levels12 months following randomizationITT populationmg/dLMEAN
SECONDARYTotal Cholesterol Levels12 months following randomizationITT populationmg/dLMEAN
SECONDARYTriglycerides Levels12 months post randomizationITT populationmg/dLMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02478359/outcomes